Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC)

Journal of Virology
K DasE Arnold

Abstract

Success in treating hepatitis B virus (HBV) infection with nucleoside analog drugs like lamivudine is limited by the emergence of drug-resistant viral strains upon prolonged therapy. The predominant lamivudine resistance mutations in HBV-infected patients are Met552IIe and Met552Val (Met552Ile/Val), frequently in association with a second mutation, Leu528Met. The effects of Leu528Met, Met552Ile, and Met552Val mutations on the binding of HBV polymerase inhibitors and the natural substrate dCTP were evaluated using an in vitro HBV polymerase assay. Susceptibility to lamivudine triphosphate (3TCTP), emtricitabine triphosphate (FTCTP), adefovir diphosphate, penciclovir triphosphate, and lobucavir triphosphate was assessed by determination of inhibition constants (K(i)). Recognition of the natural substrate, dCTP, was assessed by determination of Km values. The results from the in vitro studies were as follows: (i) dCTP substrate binding was largely unaffected by the mutations, with Km changing moderately, only in a range of 0.6 to 2.6-fold; (ii) K(i)s for 3TCTP and FTCTP against Met552Ile/Val mutant HBV polymerases were increased 8- to 30-fold; and (iii) the Leu528Met mutation had a modest effect on direct binding of these beta-L-o...Continue Reading

References

Jan 1, 1979·Methods in Enzymology·W W Cleland
Dec 21, 1995·The New England Journal of Medicine·J L DienstagM Rubin
Jul 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·A Jacobo-MolinaP Clark
Jun 15, 1995·Structure·G J Kleywegt, T A Jones
May 30, 1996·The New England Journal of Medicine·C NiederauD Häussinger
Sep 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R LingT J Harrison
Dec 1, 1996·Journal of Biomolecular NMR·R A LaskowskiJ M Thornton
Feb 14, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M MelegariJ R Wands
Apr 18, 1998·Therapeutische Umschau. Revue thérapeutique·E G Rambusch, M P Manns
Jun 10, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M I AllenL D Condreay
Jul 9, 1998·The New England Journal of Medicine·C L LaiD F Gray
Jul 22, 1998·Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progrès Des Recherches Pharmaceutiques·J M Colacino, K A Staschke
Aug 15, 1998·Digestion·J H Hoofnagle
Nov 26, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·X XiongC S Gibbs
Mar 26, 1999·The Journal of General Virology·R Ling, T J Harrison
Jun 22, 1999·The Journal of Clinical Investigation·S K Ono-NitaM Omata
Jul 27, 1999·International Journal of Antimicrobial Agents·E De Clercq
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·S G SarafianosE Arnold
Dec 22, 1999·Journal of Virological Methods·R JardiJ Guardia
Dec 29, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·X XiongC S Gibbs
Apr 29, 2000·Annals of Internal Medicine·A H Malik, W M Lee
Jun 28, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R PerrilloA Murray

❮ Previous
Next ❯

Citations

Dec 4, 2003·Journal of Hepatology·Jean-Pierre VilleneuveFabien Zoulim
Dec 31, 2003·Lancet·Ching Lung LaiThierry Poynard
Jan 8, 2004·Journal of Hepatology·Stephen Locarnini
Nov 7, 2002·Bioorganic & Medicinal Chemistry Letters·Youhoon Chong, Chung K Chu
Oct 9, 2002·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Joseph Torresi
Nov 9, 2002·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Jordan Feld, Stephen Locarnini
May 28, 2005·The Lancet Infectious Diseases·Marina Núñez, Vincent Soriano
Feb 23, 2012·Journal of Medicinal Chemistry·Hitesh K AgarwalKeykavous Parang
Apr 27, 2012·Journal of Medicinal Chemistry·Hitesh K AgarwalKeykavous Parang
Sep 21, 2010·Nature Structural & Molecular Biology·Xiongying TuEddy Arnold
Jul 9, 2003·European Journal of Biochemistry·Sung Gyoo ParkGuhung Jung
Dec 17, 2003·Journal of Gastroenterology and Hepatology·Xinxin ZhangYuan Wang
Sep 27, 2003·HIV Medicine·M G BrookUNKNOWN British HIV Association
Jul 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Huiling YangShelly Xiong
Aug 29, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Béatrice SeignèresFabien Zoulim
Oct 4, 2011·The Journal of Antimicrobial Chemotherapy·James FungMan-Fung Yuen
Nov 9, 2004·International Journal of Clinical Practice·M Danta, G Dusheiko
May 13, 2009·Antimicrobial Agents and Chemotherapy·Jie FangDaniel J Tenney
Sep 20, 2006·Antimicrobial Agents and Chemotherapy·Hiromi YatsujiKazuaki Chayama
Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Naohiro KamiyaSatoshi Yuasa
May 23, 2003·Antimicrobial Agents and Chemotherapy·Béatrice SeignèresFabien Zoulim
Sep 25, 2004·Antimicrobial Agents and Chemotherapy·William E DelaneyShelly Xiong
Jun 28, 2005·Antimicrobial Agents and Chemotherapy·S Balakrishna PaiRaymond F Schinazi
Oct 9, 2004·Journal of Clinical Microbiology·Anna LindströmJan Albert
Feb 3, 2007·Journal of Virology·David R LangleyDaniel J Tenney
Apr 16, 2010·Journal of Virology·Cristina Ferrer-OrtaNuria Verdaguer
Jan 13, 2012·Journal of Virology·Maureen J DonlinJohn E Tavis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
S G SarafianosE Arnold
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
L StuyverR F Schinazi
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
M I AllenL D Condreay
© 2021 Meta ULC. All rights reserved